MYCN is a known transcriptional activator of TERT, yet MYCN amplifications were mutually exclusive with TERT rearrangements, as well as ATRX alterations, a gene associated with alternate lengthening of telomeres, suggesting that these alterations may share a similar role in neuroblastoma [75]. Here, ATRX is linked to neuroblastoma.